文献速递白血病造血干细胞移植与细胞治疗

Lama4在造血再生和急性髓系白血病进展中的关键作用

Critical role of Lama4 for hematopoiesis regeneration and acute myeloid leukemia progression.
PubMed 文献 · Blood · 2022-01-01

研究报道小鼠中Lama4缺失导致辐照后造血再生受损并伴随骨髓微环境组成改变和炎症,在MLL-AF9急性髓系白血病移植模型中Lama4缺失加速白血病进展和复发。Lama4缺失的间充质干细胞分子改变增强抗氧化活性,促进白血病干细胞增殖和对阿糖胞苷的耐药,并增加线粒体向白血病细胞转移。抑制或敲低人源间充质干细胞中的LAMA4促进人急性髓系白血病细胞增殖和化疗保护。

要点

  • 小鼠Lama4缺失导致辐照后造血再生受损,伴随骨髓微环境组成改变和炎症。
  • Lama4缺失小鼠在MLL-AF9急性髓系白血病模型中白血病进展和复发加速。
  • Lama4缺失间充质干细胞增强抗氧化活性、促进白血病干细胞增殖和对阿糖胞苷耐药。

核心结论

  • 研究首次证明Lama4在阻碍急性髓系白血病进展和化疗耐药中起关键作用。
  • 靶向Lama4信号通路可能为急性髓系白血病提供潜在的新治疗选择。

研究设计与样本

  • 小鼠Lama4缺失模型及移植诱导的MLL-AF9急性髓系白血病小鼠模型研究。
  • 体外使用Lama4缺失间充质干细胞与人源间充质干细胞进行机制研究。

主要发现

  • Lama4缺失小鼠辐照后造血再生受损,伴随骨髓微环境组成改变和炎症。
  • Lama4缺失小鼠在MLL-AF9急性髓系白血病模型中白血病进展和复发加速。
  • Lama4缺失间充质干细胞分子改变包括炎症细胞因子上调,有利于白血病生长。
  • Lama4缺失间充质干细胞抗氧化活性增加,促进白血病干细胞增殖和对阿糖胞苷耐药。
  • 体外Lama4缺失间充质干细胞向白血病细胞的线粒体转移增加,白血病细胞内活性氧降低。

关键数值与推荐

  • Lama4缺失小鼠在MLL-AF9急性髓系白血病模型中白血病进展和复发加速。
  • Lama4缺失间充质干细胞促进白血病干细胞增殖和对阿糖胞苷耐药。
  • 抑制或敲低人源间充质干细胞中的LAMA4促进人急性髓系白血病细胞增殖和化疗保护。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Impairment of normal hematopoiesis and leukemia progression are 2 well-linked processes during leukemia development and are controlled by the bone marrow (BM) niche. Extracellular matrix proteins, including laminin, are important BM niche components. However, their role in hematopoiesis regeneration and leukemia is unknown. Laminin α4 (Lama4), a major receptor-binding chain of several laminins, is altered in BM niches in mice with acute myeloid leukemia (AML). So far, the impact of Lama4 on leukemia progression remains unknown. We here report that Lama4 deletion in mice resulted in impaired hematopoiesis regeneration following irradiation-induced stress, which is accompanied by altered BM niche composition and inflammation. Importantly, in a transplantation-induced MLL-AF9 AML mouse model, we demonstrate accelerated AML progression and relapse in Lama4-/- mice. Upon AML exposure, Lama4-/- mesenchymal stem cells (MSCs) exhibited dramatic molecular alterations, including upregulation of inflammatory cytokines that favor AML growth. Lama4-/- MSCs displayed increased antioxidant activities and promoted AML stem cell proliferation and chemoresistance to cytarabine, which was accompanied by increased mitochondrial transfer from the MSCs to AML cells and reduced reactive oxygen species in AML cells in vitro. Similarly, we detected lower levels of reactive oxygen species in AML cells from Lama4-/- mice post-cytarabine treatment. Notably, LAMA4 inhibition or knockdown in human MSCs promoted human AML cell proliferation and chemoprotection. Together, our study for the first time demonstrates the critical role of Lama4 in impeding AML progression and chemoresistance. Targeting Lama4 signaling pathways may offer potential new therapeutic options for AML.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Cai H, Kondo M, Sandhow L, et al. Critical role of Lama4 for hematopoiesis regeneration and acute myeloid leukemia progression. Blood. 2022. PMID: 34958665. doi:10.1182/blood.2021011510

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。